Methsuximide 300 mg/1
Methsuximide · CAPSULE · ANI Pharmaceuticals, Inc.
No Recall History
Plain English
Methsuximide is a capsule containing methsuximide at 300 mg/1, taken oral. Manufactured by ANI Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Methsuximide
- Generic Name
- Methsuximide
- NDC Code (Product)
70954-228- Manufacturer
- ANI Pharmaceuticals, Inc.
- Strength
- 300 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA217213
- Drug Class
- Anti-epileptic Agent [EPC]
- Marketing Start
- 05/01/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective10 reports
off label use8 reports
multiple-drug resistance5 reports
seizure5 reports
toxicity to various agents5 reports
drug interaction4 reports
product use in unapproved indication4 reports
somnolence4 reports
thrombocytopenia4 reports
treatment failure4 reports
Frequently Asked Questions
What is Methsuximide used for?
Methsuximide contains Methsuximide. It is a capsule taken oral. Consult your doctor for specific uses.
Is Methsuximide a controlled substance?
Methsuximide is not classified as a controlled substance by the DEA.
What is the generic name for Methsuximide?
The generic name for Methsuximide is Methsuximide. There are 1 other brand versions of Methsuximide.
What is the NDC code for Methsuximide 300 mg/1?
The NDC (National Drug Code) for Methsuximide 300 mg/1 is 70954-228, listed by ANI Pharmaceuticals, Inc..